Alexander Pietras, Associate Professor at Lund University, have been awarded an European Research Council Consolidator Grant (ERC-CoG) for the project - RESISTANCEPROGRAMS. The research group will explore and exploite the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors.
Glioblastoma multiforme (GBM), the deadliest form of brain tumor, occurs in both children and adults and affect 400-500 people annually in Sweden. Despite different forms of treatment, the cancer reoccur as incurable relapses and the average survival from diagnosis is only 12-15 months. By investigating the radiation resistant stem-like tumor cells in the microenvironment one hope to find novel therapeutic targeting the resitant cells in the brain tumor.
313 new ERC Consolidator Grants to tackle big scientific questions